Bristol-Myers Squibb

YTD

ALL

Trade Bristol-Myers Squibb 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BMY

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies.

CEO

Christopher S. Boerner

CEOChristopher S. Boerner

Employees

34,100

Employees34,100

Headquarters

Princeton, New Jersey

HeadquartersPrinceton, New Jersey

Founded

1933

Founded1933

Employees

34,100

Employees34,100

BMY Key Statistics

Market cap

95.43B

Market cap95.43B

Price-Earnings ratio

19.22

Price-Earnings ratio19.22

Dividend yield

5.16%

Dividend yield5.16%

Average volume

9.94M

Average volume9.94M

High today

$47.79

High today$47.79

Low today

$46.65

Low today$46.65

Open price

$47.63

Open price$47.63

Volume

7.87M

Volume7.87M

52 Week high

$63.33

52 Week high$63.33

52 Week low

$42.96

52 Week low$42.96

BMY News

TipRanks 3d

Hold Rating for Bristol-Myers Squibb Amid Uncertain Revenue Projections and Fair Valuation

Analyst Evan Seigerman of BMO Capital maintained a Hold rating on Bristol-Myers Squibb, retaining the price target of $47.00. Elevate Your Investing Strategy: T...

TipRanks 6d

Bristol-Myers Squibb’s Promising Phase 3 Study on KarXT for Bipolar-I Disorder

Bristol-Myers Squibb Company ((BMY)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium...

TipRanks 6d

Bristol-Myers Squibb’s New Lung Cancer Study: Potential Market Impact

Bristol-Myers Squibb Company ((BMY)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at...

Analyst ratings

74%

of 27 ratings

Buy

22.2%

Hold

74.1%

Sell

3.7%

More BMY News

TipRanks 6d

Bristol-Myers Squibb’s Luspatercept Study: Market Insights and Implications

Bristol-Myers Squibb Company ((BMY)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium...

TipRanks 6d

Bristol-Myers Squibb’s New Lung Cancer Study: Market Implications and Progress

Bristol-Myers Squibb Company ((BMY)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium...

People also own

Based on the portfolios of people who own BMY. This list is generated using Robinhood data, and it’s not a recommendation.